BEGIN:VCALENDAR VERSION:2.0 PRODID:icalendar-ruby CALSCALE:GREGORIAN BEGIN:VEVENT DTSTAMP:20240328T162844Z UID:7e9ddf37-3c05-491e-b4a5-f99b5798ecc3 DTSTART:20210924T080000 DTEND:20210925T080000 CLASS:PRIVATE DESCRIPTION:
ConferenceSeries LLC Ltd proudly an nounces the commencement of its &ldquo\;12th World Drug Delivery Summit&rd quo\; which is going to be held during September 24-25\, 2020 at Chicago\, USA. The conference highlights the theme &ldquo\;Frontiers Innovations in Drug Delivery Technology&rdquo\;. The event offers a best platform with i ts well organized scientific program to the audience which includes intera ctive panel discussions\, keynote lectures\, plenary talks and poster sess ions on the topics Drug delivery\, Novel Approaches on Product Development \, Biopharmaceutics\, vaccine drug delivery\, Pharmaceutical Innovation in the 21st Century\, New scientific approaches to international regulatory standards. The conference invites delegates from Leading Universities\, Ph armaceutical companies\, Formulation Scientists\, Medical Devices\, Resear chers\, Healthcare professionals\, students\, business delegates and Young researchers across the globe providing a better podium\, interconnecting the latest research\, technological developments in the arena as well as t herapeutic aspects. Participating at Drug Delivery International conferenc e will be an excellent opportunity to meet eminent personalities in the fi elds of pharmaceutics and learn about the latest technological advancement s. Drug Delivery is the method or process of administering a pharmaceutica l compound to achieve a therapeutic effect in humans or animals. The sessi ons of this conference are more concerned with drug delivery technology\, novel drug delivery systems\, novel routes of administration\, pharmaceuti cal nanotechnology\, nucleic acid-based drug delivery\, smart drug deliver y\, vaccine design and delivery technology\, drug delivery companies and m arkets\, biopharmaceutics as novel technique in drug delivery\, drug devic es and device development\, peptide and protein drug delivery\, drug deliv ery equipment&rsquo\;s and machinery and major challenges in drug delivery and Pharmaceutical companies.
\n\nPerformances of intelligent drug delivery systems are continuously improved with the purpose to maximize th erapeutic activity and to minimize undesirable side-effects. This summit d escribes the advanced drug delivery systems based on sustain drug delivery \, targeted drug delivery system\, controlled drug delivery\, ocular drug delivery\, transdermal drug delivery\, transmucosal drug delivery through novel routes as Intranasal\, parenteral routes\, buccal routes\, tropical routes with pharmacology aspects. Pharmaceutical nanotechnology embraces a pplications of nanoscience to the pharmacy as polymeric nanoparticles\, Li posomes\, dendrimers\, nanomedicine\, nanoemulsion for drug delivery.
\ n\nDrug Delivery is one of the major contributors in global economic pr ogress. The global pharmaceuticals market\, in 2020\, was $120 billion. Th e global pharmaceutical industry is currently worth over $145 billion\, ac cording to research conducted. The industry should exceed $167 billion in 2020. Realizing the importance\, Conference series LLC Ltd is organizing 1 1th World Drug Delivery conference in Baltimore\, USA this year paving way for sharing views and research\, which will help the scientific world to adopt solutions for the problems of critical importance.
\n\nDrug De livery 2020 is Anticipating 300+ Participation (70 Industry: 30 Academia) 10+ Keynote Speakers\, 50+ Plenary Speakers\, 20+ Exhibitors\, 14 Innovati ve Educational Sessions\, 5+ Workshops\, B2B Meetings
\n\nWh y Should I Attend?
\n\nBridging the gap between Academia an d Industry in novel research methods of DDS Meeting with 70+ industrial ex perts\, 30+ academic speakers\, 50+Pharmaceutical Companies\, 120+decision -makers interacting. Finding novel opportunities of doing NDDS business an d dynamically providing the &ldquo\;value addition&rdquo\; to pharmaceutic al R&\;D businesses. Novel approaches about the drug delivery systems d evelopment and industrializing insights &\; gain the latest technologie s about novel drug delivery systems and applications Emphasis on novel str ategies for formulation and drug delivery system&rsquo\;s latest updates t o drive your market share accordingly. Learn on the applications of novel DDS for treating major diseases to progress the drug portfolio industriali zation pathways. The global advanced drug delivery market should grow from roughly $178.8 billion in 2020 to nearly $227.3 billion by 2020\, with a compound annual growth rate (CAGR) of 4.9%. Europe contributed about 27% o f the total drug delivery market in 2010 and was $36 billion and is expect ed to grow to $49 billion by 2020 at a CAGR of 5.6%. Given its predicted a nnual growth\, the market represents a considerable business opportunity\, which has been reflected in the increasing number of drug delivery specia lists. The global market for drug delivery systems in 2010 was $131.6 bill ion and is expected to rise at a compound annual growth rate (CAGR) of 5% and reach nearly $175.6 billion by 2020. With a large number of pharmaceut ical\, chemistry\, biomedical departments and companies involved in drug d elivery research U.S constitute the highest number of researchers going on . Approx. of 10 universities in Houston out of 500 universities in the USA are into drug delivery research. There are approx. 230 major Drug deliver y companies all over the globe including that of 100 in USA and 10 in NewO rleans into drug delivery research apart from a large number of pharmaceut ical companies.
\n\nSessions/Tracks Track 1 : Drug Delivery Technology
\n\nDrug Delivery Conferences at tains greater global significance as Drug Delivery plays an indispensable role in the future of the pharmaceutical research Novel drug delivery syst em is a mechanism by which a drug is delivered in such a way that it can r each the maximum level of efficacy. The conference includes topics like Li pid Polymers to enhance drug delivery technology by providing controlled r elease of therapeutic agents in constant doses over long periods\, cyclic dosage\, and methodical release of both hydrophilic and hydrophobic drugs. In vitro and in vivo dissolution testing is required to ensure that the d rug dissolves at a steady and consistent rate in batch to batch of formula ted drug product. The dissolution rate of poorly soluble drugs can be incr eased by dissolving them in liquid hydrophilic vehicles followed by soakin g on highly porous materials. The major objective is to deliver an innovat ive speech on the latest Targeted drug delivery method for providing medic ation to a patient in a manner which increases the concentration of the me dication in some parts of the body relative to others. Pharmacokinetic beh avior in drug design and drug development for safety issues arise either a s a result of animal toxicity testing or in the clinical program itself
\n\n12th World Drug Delivery Summit\, September 24-25\, 2020 |Chicago\ , USA\; 16th Global Summit on Toxicology and Applied Pharmacology\, Octobe r 15-16\, 2020| Las Vegas\, USA\; 13th International Conference on Biologi cs and Biosimilars\, October 24-25\, 2020| Boston\, USA\; 13th Internation al Conference on Biopharma and Biotherapeutics\, October 24-25\, 2020| Bos ton\, USA\;
\n\nTrack 2: Novel Drug Delivery Systems
\n\nFor the target of amplifying knowledge on the current research ers on developing drug delivery systems via novel techniques for Pharmaceu tical formulation development\, Drug Delivery conference is centred around quality topics including Liposomes\, Dendrimer\, Targeted Drug Delivery d esign\, versatile polymer in Drug Delivery and Controlled Drug Delivery\, Trans mucosal Drug Delivery\, Blood Brain Barrier\, Optimization of pharma ceutical products\, Sustained Drug Delivery Systems\, are an uniquely arch itectured session which plays an important role in the fields of pharmaceu tical formulation development and Pharmacology.
\n\nCongress on Inno vation in Drug Delivery (APGI)\, Controlled Release Society (CRS)\, Intern ational Society for Aerosols in Medicine (ISAM)\, The Pharmaceutical and H ealthcare Sciences Society (PHSS).
\n\nTrack 3: Routes of Dr ug Administration
\n\nAimed and specially designed session for young and senior researcher from academic on drug dosage formulations through novel routes in drug delivery where researcher interested for deve loping novel routes to minimize drug interactions occur through common rou tes by which a drug is brought into contact with the body. Different dosag e forms are manufactures by pharmaceutical companies according to drug des igning to maximize bioavailability. Session includes different routes of a dministration like Topical drug delivery via a large range of classes incl uding but not limited to creams\, foams\, gels\, lotions\, and ointments. Pulmonary drug delivery system route is gaining much importance in the pre sent day research field as it enables to target the drug delivery directly to lung both for local and systemic treatment. Nasal drug delivery an alt ernative route restricted to intravenous administration this area has been widely investigated in recent years by academics. Topics like other novel routes wise Vaginal drug delivery covers self-insertion creams\, foams\, gels\, irrigations and tablets\, are known to reside in the vaginal cavity . Oral Drug Delivery routes to reaching different parts of the body via th e bloodstream. Injectable formulations intended for administration by inje ction\, infusion or implantation and placental development into the body.< /p>\n\n
9th Asian Biologics and Biosimilars Congress\, August 20-22\, 20 20| Tokyo\, Japan\; International Conference on Pediatric Hospital Medicin e\, August 29-30\, 2020| Boston\, USA\; 4th International Conference and E xpo on Drug Discovery\, Designing &\; Development\, September 06-07\, 2 020| London\, UK\; 6th International Conference and Exhibition on Pharmaco gnosy\, Phytochemistry &\; Natural Products\, September 17-18\, 2020|Be ijing\, China
\n\nTrack 4: Pharmaceutical Nanotechnology
\n\nPharmaceutical Nanotechnology for Drug Delivery using Nano technology session plays major role in the future of pharmaceutical resear ch. In this session\, we will go over several of the most important featur es of nanotechnology\, anticancer drug development \, pharmocology of canc er drugs\, that will impact our lives but we will also talk about what nan otechnology itself will be like in the future and Investigator specificall y from cancer therapy. Interestingly pharmaceutical sciences are using nan oparticles to reduce toxicity and side effects of drugs and up to recently did not realize that carrier systems themselves may impose risks to the p atient. Nano technology session includes drug delivery using nanotechnolog y\, Pharmaceutical technology\, Nanoparticles permeability to BBB\, Cancer drug targets\, Nanoparticles application\, Pancreatic Cancer\, Nanoliposo me-mediated delivery\, MicroRNA therapeutics\, recent breakthroughs in nan oparticle design to demonstrate their high potential as multifunctional dr ug delivery nanocarrier\, Carriers for nanotechnology\, various nanostruct ures\, magnetic nanoparticles. In this review Polymer Nanotechnology for D rug Delivery\, Nano composite materials\, to deliver highly efficient ther apeutic compounds to patient a future aspect of Nanotechnology has a vast future ahead of it and we are constantly making breakthroughs in this indu stry every day.
\n\nApplied Pharmaceutical Nanotechnology Society (A PN)\, Controlled Release Society (CRS)\, The Pharmaceutical and Healthcare Sciences Society (PHSS).
\n\nTrack 5: Nucleic Acid Based Dr ug Delivery
\n\nNucleic acids science and technologies expe rience tremendous progress and changes. The conference will feature promin ent experts discussing latest advances in nucleic acids\, industrial pharm acy\, pharmaceutical design\, drug targeting\, anticancer drug development \, Nano pharmaceutics\, research and development: TNA for treating cancer and viral diseases in the near future for drug delivery includes novel Rn ai-Based Therapy\, advances in siRNA delivery\, oligonucleotide drug deliv ery\, viral gene therapy and Artificial microRNAs\, non-coding RNA (miRNA\ , piRNA\, lncRNA\, and lincRNA) this architect session to play an importan t role in the fields of cancer targeting and pharmaceutical nanotechnology .
\n\n11th International Conference on Pharmacovigilance &\; Drug Safety\, June 21-22\, 2020| London\, UK\; 4th International Conference on Drug Discovery\, Designing and Development\, June 27-28\, 2020| Vancouver \, Canada\; 11th International Conference on Pharmacology and Ethnopharmac ology\, July 18-19\, 2020| Atlanta\, USA\; International Conference on Pha rmaceutical Oncology\, July 18-19\, 2020| Atlanta\, USA\; 12th Global Ethn omedicine and Ethnopharmacology Conference\, August 20-21\, 2020|Tokyo\, J apan
\n\nTrack 6: Smart Drug Delivery Systems
\n \nTo maximize knowledge of the current researcher on developing drug de livery via Pharmaceutical formulation\, Smart Drug Delivery conference the med quality topics on Drug Targeting\, Drug Designing\, Drug evaluation\, Drug Delivery and Therapeutics\, Biodegradable polymers\, Dendrimer a vers atile polymer in drug delivery are a uniquely architect session to play an important role in the fields of nanotechnology\, pharmaceutical and medic inal chemistry. Major drugs driving growth of the overall smart drug deliv ery market include Angiomax\, Copaxone\, Forteo\, Sandostatin\, Velcade\, Victoza and Zoladex
\n\nCongress on Innovation in Drug Delivery (APG I)\, Controlled Release Society (CRS)\, International Society for Aerosols in Medicine (ISAM)\, The Pharmaceutical and Healthcare Sciences Society ( PHSS).
\n\nTrack 7: Vaccine Based Drug Delivery Technology strong>
\n\nVaccine is multidisciplinary scientific field that is cu rrently undergoing rapid development. An important component of cancer vac cines is the development of novel vaccine strategies\, this session includ es Laser technology for Vaccine Adjuvants\, Challenges and opportunities F or Vaccine Delivery\, These advances promise to accelerate the development and testing Jet injectors\, micro needles\, Needle free drug delivery tec hnology\, is an innovative technique to deliver drugs into a person'\;s body without piercing their skin.
\n\n11th European Biosimilars Con gress\, April 26-27\, 2020| Rome\, Italy\; 15th Annual European Pharma Con gress\, May 07-09\, 2020| Frankfurt\, Germany\; 5th International Conferen ce on Pain Management and Pain Medicine\, May 21-22\, 2020 | New York\, US A\; International Conference on Pharmaceutical Research and Development\, June 06-07\, 2020 | Baltimore\, USA\; 8th International Conference on cGMP \, GCP &\; Regulatory Affairs\, June 08-09\, 2020| Baltimore\, USA
\ n\nTrack 8: Drug Delivery Companies and Markets
\n\ nDrug Delivery Companies and Market session is beginning to change for small\, medium\, and large scale pharmaceutical Co\, biopharmaceutical Man ufacturing and Industries \, generic drugs companies\, contract drug deliv ery companies which can manifest from development to manufacturing. Addres sing these instabilities is a great challenge\, because of the complexity of the Clinical bio therapeutics themselves. This session includes Rheolog ical behavior\, Pharmaceutical Guidelines\, Pharmaceutical companies and r egulatory guidelines perspectives\, Advances in computational modeling for bioavailability\, drug Stability of Pharmaceutical products which are dri ving crucial research into new vaccines and medicines. The pharmaceutical industry and the public sector are thinking differently than before about how to improve access to medicines and advance research and development fo r neglected diseases.
\n\nControlled Release Society (CRS)\, Interna tional Society for Aerosols in Medicine (ISAM)\, The Pharmaceutical and He althcare Sciences Society (PHSS).
\n\nTrack 9: Bio therapeut ics as Novel Technique in Drug Delivery
\n\nAs new product formats progress through development and into the regulatory process\, the role of Bio therapeutics as Novel Technique in Drug Delivery is important scope. The demand for Biopharmaceuticals manufacturing and industry is co ntinuously increasing\, because many Therapeutic Agents are reaching later stage clinical trials. Most bio therapeutic drugs are recombinant monoclo nal antibodies which are widely produced in mammalian cell lines because o f the need for post-translational modifications that should be alike or at least similar to those obtained in humans. Thus\, there is an increase in the market for cell line development. Moreover\, advancements in upstream processing technologies have led to improvement in speed and efficiency o f generating robust and highly productive cell line for large scale produc tion of protein therapeutics and has propelled the market for cell line de velopment. Major drugs driving growth of the overall smart drug delivery m arket include Angiomax\, Copaxone\, Forteo\, Sandostatin\, Velcade\, Victo za\, Zoladex\, Beckton Dickinson &\; Company (U.S.)\, Beckman Coulter ( U.S.)\, Boehringer Ingelheim Group (Germany)\, Catalent Inc. (U.S.)\, CMC Biologics A/S (Denmark)\, Lonza Group Ltd. (Switzerland)\, EMD Millipore ( U.S.)\, Partec (Sysmex Corporation) (Japan)\, ProBioGen AG (Germany)\, Sel exis SA (Germany)\, Sigma-Aldrich Co. LLC.
\n\nAccording to a New Ma rket Research &ldquo\;Bio therapeutics as Novel Technique in Drug Delivery Global Industry Analysis\, Size\, Share\, Growth\, Trends\, and Forecast 2020 - 2022&rdquo\;\, the Bio therapeutics as Novel Technique in Drug Deli very was valued at US$56.03 mn in 2020 and is anticipated to expand at a C AGR of 7.5% from 2020 to 2022 to reach US$99.84 mn by 2022.
\n\n12th World Congress on Pharmaceutical Sciences and Innovations in Pharma Indus try\, February 26- 27\, 2020| London\, UK\; 16th International Conference and Exhibition on Pharmaceutics &\; Novel Drug Delivery Systems\, March 19-21\, 2020|Berlin\, Germany\; 5th Annual Congress on Chemistry in Drug Discovery &\; Designing\, April 16-17\, 2020| Dubai \, UAE\; Internatio nal Conference on Nano Medicine and Nanoparticles\, April 18-19\, 2020| La s Vegas\, USA\; 4th International Conference on Antibiotics: R&\;D\, B2 B\, April 20-21\, 2020| Las Vegas\, USA\;
\n\nTrack 10: Drug Delivery and Device Development
\n\nIn this session we wil l focus on Medical Devices designed for drug delivery through the pulmonar y and nasal routes. These routes are of interest for local delivery\, as i n asthma\, but also for rapid delivery of drugs to the system circulation and direct delivery to the central nervous system. Devices that account fo r specific anatomical and physiological features of the intranasal and pul monary routes will be featured. Drug delivery devices are specialized tool s for the delivery of a drug or therapeutic agent via a specific route of administration. Such devices are used as part of one or more medical treat ments. Many in the industry have long felt overly burdened by what they co nsider to be an unnecessarily complex approval process. Critics claim it i mpedes innovation and delays the availability of better health care. To ch ange that perception\, the FDA last year announced $40 million to a new Me dical Device Innovation Consortium (MDIC) charged with simplifying the pro cess of designing and testing new technologies. With input from industry\, government\, and other nonprofit organizations\, public-private MDIC will prioritize the regulatory science needs of the medical device community a nd fund projects to streamline the process.
\n\nCurrent research on femtosecond laser microfabrication of fluidic devices is introduced to pre sent their research to elaborate. The research on microfluidics provides h ighly sensitive microfluidic sensors for practical applications with signi ficant advantages of portability\, efficiency\, sensitivity\, versatility\ , and low cost.
\n\nCongress on Innovation in Drug Delivery (APGI )\ , Controlled Release Society (CRS)\, International Society for Aerosols in Medicine (ISAM)\, The Pharmaceutical and Healthcare Sciences Society (PHS S).
\n\nTrack 11: Recent Advances in Drug Delivery< /p>\n\n
The scope of this session on research in Recent Advances in Drug Delivery includes
\n\nOpportunities and challenges for Drug Deliver y Market in the Pharmaceutical analytical Market to forecasts for Drug Del ivery Market in the global Pharmaceutical companies from 2009 to 2025. Ses sions includes solid pharmaceutical Drug Dosage Formulations\, drug bioava ilability\, Tumor targeting\, Tumour Biomarkers\, coating materials. The k ey geographies including the US\, Europe\, Japan and Emerging Hotspots suc h as India\, Singapore and ChinaTechnology trends in Drug Delivery Market that shape the industryQualitative analysis of the market drivers\, barrie rs\, future outlook and challenges for the Drug Delivery Market Analysis o f competitive landscape and the leading market players.
\n\n11th Eur opean Biosimilars Congress\, April 26-27\, 2020| Rome\, Italy\; 15th Annua l European Pharma Congress\, May 07-09\, 2020| Frankfurt\, Germany\; 5th I nternational Conference on Pain Management and Pain Medicine\, May 21-22\, 2020 | New York\, USA\; International Conference on Pharmaceutical Resear ch and Development\, June 06-07\, 2020 | Baltimore\, USA\; 8th Internation al Conference on cGMP\, GCP &\; Regulatory Affairs\, June 08-09\, 2020| Baltimore\, USA
\n\nTrack 12: Major challenges in Drug Deli very
\n\nBy focusing on Major challenges in Drug Delivery i n the drug-delivery technology market
\n\nSession includes: Reducing Patient Compliance\, Drug Delivery of poorly soluble drugs\, Overcoming c hallenges in pediatric drug delivery\, controlling the addictive nature of drugs\, Polymeric enhancement.
\n\nThere is an increasing demand fo r effective and\, ideally\, non-invasive drug-delivery methods. This is es pecially the case for the biopharmaceutical sector\, which has experienced an overwhelming growth due to advances in biotechnology. In 2009\, over $ 12 billion were invested in biologics / biotechnology research and develop ment (R&\;D)\, representing a 26% share in the total R&\;D expenditu re. A recent report by the Pharmaceutical Research and Manufacturers of Am erica (PhRMA) states that in 2020 there were 901 biological in development \, targeting more than 100 diseases.
\n\nCongress on Innovation in D rug Delivery (APGI)\, Controlled Release Society (CRS)\, International Soc iety for Aerosols in Medicine (ISAM)\, The Pharmaceutical and Healthcare S ciences Society (PHSS).
\n\nTrack 13: Peptide and Protein Dr ug Delivery
\n\nThis session and track is intended to assis t pharmaceutical scientists in the development of stable Medicinal Prepara tions of Proteins and Peptides during the early stages of the product deve lopment process for Pharmaceutical technology providing a comprehensive re view of mechanisms and causes of protein instability in formulation develo pment\, coverage of accelerated stability testing methods and relevant ana lytical methods\, and an overview of the drug substance manufacturing proc ess. Preformulation and the development of traditional solutions and lyoph ilized formulations frequently used for intravenous delivery and non-tradi tional formulations are also addressed.
\n\nThe drug delivery techno logy market is expected to reach USD 1\,504.7 Billion by 2020 from USD 1\, 048.1 Billion in 2020\, growing at a CAGR of 7.5% from 2020 to 2020. Facto rs such as rising prevalence of chronic diseases\, growth of the biologics market\, new product launches\, and drug innovation and technological adv ancements are driving the growth of this market. On the other hand\, paten t expiry and patent cliff\, increase in the injuries and side effects are hindering the growth of this market.
\n\n11th International Conferen ce on Pharmacovigilance &\; Drug Safety\, June 21-22\, 2020| London\, U K\; 4th International Conference on Drug Discovery\, Designing and Develop ment\, June 27-28\, 2020| Vancouver\, Canada\; 11th International Conferen ce on Pharmacology and Ethnopharmacology\, July 18-19\, 2020| Atlanta\, US A\; International Conference on Pharmaceutical Oncology\, July 18-19\, 202 0| Atlanta\, USA\; 12th Global Ethnomedicine and Ethnopharmacology Confere nce\, August 20-21\, 2020|Tokyo\, Japan
\n\nTrack 14: Drug D elivery Equipment and Machinery
\n\nEquipment and Machinery for Drug Delivery session includes major area participants/ Vendors\, Eng ineers in Equipments from Laboratory equipments\, Analytical Equipments\, Auto Injectors\, Semi-Automatic R&\;D Equipment\, Large volume Producti on Machineries and Drug Delivery Pilot Equipments.
\n\nCongress on I nnovation in Drug Delivery (APGI)\, Controlled Release Society (CRS)\, Int ernational Society for Aerosols in Medicine (ISAM)\, The Pharmaceutical an d Healthcare Sciences Society (PHSS).
\n\nTrack 15: Business Opportunities in Drug Delivery
\n\nThe global market for B usiness Development of Drug Delivery Technology in 2010 was $131.6 billion and is expected to rise at a compound annual growth rate (CAGR) of 5% and reach nearly $175.6 billion by 2020. The U.S. constituted approximately 5 9% of the total drug delivery market in 2010 and was $78 billion. It is fo recast to reach nearly $103 billion in 2020 at a CAGR of 4.7%. Europe cont ributed about 27% of the total drug delivery market in 2010 and was $36 bi llion and is expected to grow to $49 billion by 2020 at a CAGR of 5.6% for 2013\, Drug Delivery Global market reached $150.3 billion\, according to BCC research. This was an increase from $142 billion the previous year. Gi ven its predicted annual growth the market represents a considerable busin ess opportunity\, which has been reflected in the increasing number of dru g delivery specialists. Consistent quality and competitive costs of produc t improves Production performance and continuity of supply and Product and technology auditing and due diligence with minimizing Regulatory Issues\, quality control\, and business development Business opportunities in drug delivery.
\n\nPlease contact the event manager Marilyn (maril
yn.b.turner(at)nyeventslist.com ) below for: - Multiple participant discou
nts - Price quotations or visa invitation letters - Payment by alternate c
hannels (PayPal\, check\, Western Union\, wire transfers etc) - Event spon
sorship NO REFUNDS ALLOWED ON REGISTRATIONS Prices may go up any time. Ser
vice fees included in pricing. -------------------------------------------
---------------------- This event is brought to you by: Conference Series
- NewYorkEventsList http://www.NyEventsList.com http://www.BostonEventsLis
t.com http://www.SFBayEventsList.com -------------------------------------
----------------------------
\nPlease contact Marilyn Turner: Phone:
+1 929 900 1853 \; Email: marilyn.turner [a] nyeventslist.com for regi
strations
VIO180510CRE MYL180626UPA
\n SUMMARY:12th World Drug Delivery Summit (CSE) BEGIN:VALARM ACTION:DISPLAY TRIGGER:-PT1H SUMMARY:12th World Drug Delivery Summit (CSE) END:VALARM END:VEVENT END:VCALENDAR